Azerbaijani student conducts research at James P. Allison Institute to enhance cancer treatment effectiveness
Amina Nurmammadova, an Azerbaijani PhD student at the MD Anderson Cancer Center Graduate School of Biomedical Sciences, ...
Pharm Exec1h
Merck Launches Phase III Trial Evaluating Zilovertamab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...